The makers of the erectile dysfunction medication Cialis are beginning to see profits for the medication after good sales and lower costs. The company that is based in Bothell said that 2nd quarter net income was 6.1 million dollars or 9c a share that compares favourably with last years loss of 30.6 million dollars or a 48c a share loss. The sales revenue increased to 18.5 million dollars from 18.1 million dollars for the previous year.

 
Market analysts said that they estimated that earning would be 5c a share and revenue would be 20.9 million dollars and last week the shares of ICOS rose by 3%. ICOS has a half share of the company Lilly Icos that makes Cialis and that gave it a 38 million earnings dividend in the 2nd quarter when compared to a loss of 0.7 million dollars the previous year.

The joint venture company has invested millions in researching and developing as well as the promotion and marketing of the drug and it is only now that financial results are being seen that justify all the expenditure. The bosses of Lilly Icos said that they were getting profitability sooner than they had originally anticipated as the sales targets were all reached or exceeded.

Cialis is the preferred erectile dysfunction drug of millions of men because it lasts for much longer than the 4 hour period that Viagra does. In fact Cialis can last for as much as 36 hours making it by far the longest lasting erectile dysfunction medication. Cialis is the best selling erectile dysfunction drug in some countries notably in France where Cialis is known as Le Weekend Pill.